Viewing StudyNCT04833114



Ignite Creation Date: 2024-05-06 @ 4:00 PM
Last Modification Date: 2024-10-26 @ 2:01 PM
Study NCT ID: NCT04833114
Status: RECRUITING
Last Update Posted: 2023-10-12
First Post: 2021-02-10

Brief Title: Polatuzumab Vedotin Plus Rituximab Ifosfamide Carboplatin and Etoposide Pola-R-ICE Versus R-ICE Alone in Second Line Treatment of Diffuse Large B-cell Lymphoma DLBCL
Sponsor: GWT-TUD GmbH
Organization: GWT-TUD GmbH

Organization Data

Organization: GWT-TUD GmbH
Class: OTHER
Study ID: Pola-R-ICE
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: GWT-TUD GmbH
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Hoffmann-La Roche INDUSTRY